Nasal allergies in the Latin American population: Results from the Allergies in Latin America survey

Nasal allergies in the Latin American population: Results from the Allergies in Latin America survey

Author Neffen, Hugo Google Scholar
Mello, Joao F. Google Scholar
Sole, Dirceu Google Scholar
Naspitz, Charles K. Autor UNIFESP Google Scholar
Eduardo Dodero, Alberto Google Scholar
Leon Garza, Hector Google Scholar
Novelo Guerra, Edgard Google Scholar
Baez-Loyola, Carlos Google Scholar
Boyle, John M. Google Scholar
Wingertzahn, Mark A. Google Scholar
Institution Childrens Hosp Orlando Alassia
Universidade de São Paulo (USP)
Universidade Federal de São Paulo (UNIFESP)
Univ Buenos Aires
Univ Autonoma Mexico
Mexican Assoc Resp Care
Hosp Angeles de las Lomas
Univ Nacl Autonoma Mexico
Schulman Ronca & Bucuvalas Inc
Nycomed GmbH
Abstract Allergies in Latin America is the first cross-national survey that describes the symptoms, impact, and treatment of nasal allergies (NAs) in individuals >= 4 years old in Latin America (LA). in total, 22,012 households across the Latin American countries of Argentina, Brazil, Chile, Colombia, Ecuador, Mexico, Peru, and Venezuela were screened for children, adolescents, and adults with a diagnosis of NA and either symptoms or treatment in the past 12 months. A total of 1088 adults and 457 children and adolescents were included and the sample was probability based to ensure valid statistical inference to the population. Approximately 7% of the LA population was diagnosed with NAs with two of three respondents stating that their allergies were seasonal or intermittent in nature. A general practice physician or otolaryngologist diagnosed the majority of individuals surveyed. Nasal congestion was the most common and bothersome symptom of NAs. Sufferers indicated that their symptoms affected productivity and sleep and had a negative impact on quality of life. Two-thirds of patients reported taking some type of medication for their NAs, with a roughly equal percentage of patients reporting taking over-the-counter versus prescription medications. Changing medications was most commonly done in those reporting inadequate efficacy. the most common reasons cited for dissatisfaction with current medications were related to inadequate effectiveness, effectiveness wearing off with chronic use, failure to provide 24-hour relief, and bothersome side effects (e.g., unpleasant taste and retrograde drainage into the esophagus). Findings from this cross-national survey on NAs have confirmed a high prevalence of physician-diagnosed NAs and a considerable negative impact on daily quality of life and work productivity as well as substantial disease management challenges in LA. Through identification of disease impact on the LA population and further defining treatment gaps, clinicians in LA may better understand and treat NAs, thus leading to improvements in overall patient satisfaction and quality of life. (Allergy Asthma Proc 31:S9-S27, 2010; doi: 10.2500/aap.2010.31.3347)
Keywords Allergic rhinitis
intranasal corticosteroids
nasal allergies
nasal allergy medications
quality of life
Language English
Sponsor Nycomed
Date 2010-05-01
Published in Allergy and Asthma Proceedings. Providence: Ocean Side Publications Inc, v. 31, n. 3, p. S9-S27, 2010.
ISSN 1088-5412 (Sherpa/Romeo, impact factor)
Publisher Ocean Side Publications Inc
Extent S9-S27
Access rights Closed access
Type Article
Web of Science ID WOS:000279416800003

Show full item record


File Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)




My Account